Pregabalin and Lidocaine in Breast Cancer Surgery to Alter Neuropathic Pain (PLAN): A Pilot Trial
Phase of Trial: Phase III
Latest Information Update: 04 Mar 2019
Price : $35 *
At a glance
- Drugs Lidocaine (Primary) ; Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms PLAN
- 04 Mar 2019 Results published in the Journal of Pain
- 20 Apr 2018 Status changed from active, no longer recruiting to completed.
- 14 Dec 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2017.